首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Pyridazine based inhibitors of p38 MAPK
Authors:McIntyre Charles J  Ponticello Gerald S  Liverton Nigel J  O'Keefe Stephen J  O'Neill Edward A  Pang Margaret  Schwartz Cheryl D  Claremon David A
Institution:Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA. mcintyre@merck.com
Abstract:Trisubstituted pyridazines were synthesized and evaluated as in vitro inhibitors of p38MAPK. The most active isomers were those possessing an aryl group alpha and a heteroaryl group beta relative to the nitrogen atom in the 2-position of the central pyridazine. Additionally, substitution in the 6-position of the central pyridazine with a variety of dialkylamino substituents afforded a set of inhibitors having good (p38 IC50 1-20 nM) in vitro activity.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号